Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study

Abstract Background Recent large clinical trials have demonstrated cardiovascular benefits of similar overall magnitude for sodium–glucose cotransporter-2 inhibitor (SGLT-2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy in subjects with type 2 diabetes. We sought to identify subgro...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Minji Sohn, Johannes W. Dietrich, Michael A. Nauck, Soo Lim
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-06-01
Edice:	Cardiovascular Diabetology
Témata:	Sodium–glucose cotransporter-2 inhibitor Glucagon-like peptide 1 receptor agonist Major adverse cardiovascular events Meta-regression Meta-analysis Diabetes mellitus, type 2
On-line přístup:	https://doi.org/10.1186/s12933-023-01877-6
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!